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Apart from elevated glucose, triglyceride and cholesterol, elevated levels of serum free-fatty acid (FFA) are observed
in diabetic patients. Increased FFA load can cause multiple dysregulation which are collectively known as lipotoxicity.
Impacts of FFA induced lipotoxicity were evaluated on various cellular responses of metabolism and stress in skeletal
muscle myotubes. Under lipotoxicity, oxidative capacity of C2C12 myotubes was reduced and decreased levels ATP
and NAD were observed. Lipotoxicity augmented non-oxidative disposal of metabolites in terms of lactate release,
IMTG and ceramide synthesis. Concomitantly, insulin resistance was also observed. These impacts were in conjunction
with increased cellular stress, inflammation, proteolysis and apoptosis. Quenching of lipotoxicity mediated oxidative
stress by antioxidant reverted its deleterious impacts and restored insulin stimulated glucose uptake. In conclusion, the
in vitro lipotoxicity makes a system which resembles in vivo pathology of muscle as seen in diabetic patients and
represents an integrated perspective of lipotoxicity on various parameters of metabolism and stress.
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Type-II diabetic patients are characterized by peripheral
insulin resistance which hinders glucose uptake capacity
of different organs and causes unregulated gluconeogenesis
together resulting in hyperglycemia (DeFronzo et al. 1992).
Unregulated rate of lipolysis is observed from insulin
resistant adipose tissue (DeFronzo et al. 1992) which
increases plasma free-fatty acid (FFA) levels. Elevated
levels of plasma FFA are considered as a causal factor
for insulin resistance (Itani et al. 2002) and reduction in
serum FFA levels improves insulin sensitivity in humans
(Qvigstad et al. 2003; Bajaj et al. 2004) as well as in animal
models of disease (Ahrén 2001).
Skeletal muscle from T2DM patients shows reduced
PI3K-Akt signaling and increased serine phosphorylation
of IRS1 which inhibits insulin signaling (Kim et al. 1999;
Krook et al. 2000; Bouzakri et al. 2003). Insulin induced
GLUT4 translocation to plasma membrane followed by* Correspondence: m.r.jagannath@connexios.com
†Equal contributors
Connexios Life Sciences Private Ltd, No. 49, First Main road, 3rd phase, JP
Nagar, Bangalore 560 078, India
© 2014 Verma et al.; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is pglucose uptake as well as glycogen storage capacity is
reduced in skeletal muscle from diabetic patients
(Kelley et al. 1996; Kim et al. 1999). Insulin resistance
not only causes impaired glucose uptake and storage
but also hinders overall oxidative capacity (Simoneau
and Kelley 1997; Schrauwen and Hesselink 2004) as
number and/or activity of mitochondria is reduced
(Kelley et al. 2002; Barazzoni 2004; Asmann et al. 2006;
Szendroedi et al. 2007). Moreover, it is evident that energy
metabolism is altered and ATP production is reduced
in diabetic muscles (Scheuermann-Freestone et al. 2003;
Asmann et al. 2006; Szendroedi et al. 2007). Similarly,
overall decreased or incomplete fat oxidation is observed
in skeletal muscle from diabetic patients (Mootha et al.
2003; Patti et al. 2003; Mensink et al. 2007; Mogensen et al.
2007; Koves et al. 2008) despite having increased ex-
pression of genes involved in fat oxidation (Turner et al.
2007; Kulkarni et al. 2012). Besides defects in fat oxidation,
increased fat uptake is observed in skeletal muscle which is
another contributing factor for increased intramyocellular
triglyceride (IMTG) storage (Bonen et al. 2004). In fact,
IMTG levels can be directly correlated with insulinn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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estingly, skeletal muscles from exercise trained subjects
are insulin sensitive despite having high IMTG content
(Goodpaster et al. 2001).
Apart from defects in metabolism, increased oxidative
and endoplasmic reticulum (ER) stress, chronic low grade
inflammation, increased proteolysis were observed in skel-
etal muscle which collectively attribute to insulin resistance
(Wang et al. 2006; Abdul-Ghani et al. 2009; Hey-Mogensen
et al. 2010). In fact, cellular stress such as oxidative stress
and stress signaling play a central role for development of
insulin resistance (Evans et al. 2002; Wei et al. 2008).
Skeletal muscle pathology under diabetes can be seen
as a combination of multiple disease states such as insu-
lin resistance, elevated oxidative stress, impaired glucose
and fat metabolism. An in vitro system that systematic-
ally addresses all these major pathologies will be an ele-
gant model to study molecular mechanism underpinning
skeletal muscle pathophysiology. Here, we use chronic
lipotoxic conditions comprising saturated free-fatty acid
(palmitate) to study various parameters of metabolism
and stress. The lipotoxic conditions resulted in increased
fatty acid uptake and elevated IMTG levels as well as in-
creased expression of genes associated with TG synthe-
sis. We find that in vitro lipotoxic conditions resulted in
impaired oxidative capacity, reduced mitochondrial num-
ber and cellular ATP levels. Non-oxidative disposal of glu-
cose in the form of lactate was increased while glycogen
storage was decreased. Increased insulin resistance, oxida-
tive stress, ER stress, apoptosis, proteolysis and low grade
inflammation were confirmed under chronic lipotoxic
conditions. Thus, our data represent an integrated view of
in vitro lipotoxic conditions mimicking muscle pathology
as seen in T2DM patients. Furthermore, we exploited this
system of chronic lipotoxicity to examine oxidative stress
as a mechanism to impair muscle metabolism. We provide
evidence that treatment with antioxidant, a known mech-
anism to counteract oxidative stress, led to reduction in
ER stress, JNK phosphorylation, IMTG storage and en-
hanced oxidative capacity. Therefore, we conclude that
oxidative stress is one of the key mechanisms for develop-
ment of lipotoxicity and its neutralization could provide
potential therapeutic advantage.
Results
Lipotoxic conditions lead to TG accumulation and
increased fatty acid uptake
To explore the impact of lipotoxic conditions on muscle
metabolism, we treated differentiated C2C12 myotubes
with 750 μM of palmitate (Watt et al. 2012) for 16 h as
described in Methods. Under this lipotoxic condition,
we did not observe any appreciable cytotoxic impact
(data not shown). To check whether this condition
mimicked diabetic muscle pathology, we measuredintramyocellular triglyceride (IMTG) levels. IMTG was
found to be increased in myotubes cultured under lipotoxic
conditions (~4 fold) as compared to those cultured under
control condition (Figure 1A). Increased IMTG levels
under lipotoxicity were also reflected in oil-o-red staining
(Figure 1B, C). This increase in IMTG was accompanied by
increased fatty acid uptake which was 49% higher under
lipotoxic conditions (Figure 1D). To test whether lipotoxic
conditions increased TG synthesis capacity of myotubes, we
measured expression of genes involved in TG synthesis. We
observed a significant increase in expression of genes re-
quired for fatty acid synthesis (FASN, 1.4 fold) and TG syn-
thesis from fatty acids (GPAM, 1.6 fold and LIPIN, 1.4 fold)
under lipotoxic conditions (Figure 1E). Hence, fatty acid
uptake, TG synthesis and IMTG storage were increased in
skeletal muscle myotubes under lipotoxic conditions.
Attenuated fatty acid oxidation and mitochondrial
biogenesis under lipotoxic conditions
Next we studied the impact of lipotoxicity on fatty acid
oxidation by estimating the activity of 3-hydroxyacyl-CoA
dehydrogenase (HADH). Lipotoxic conditions reduced fatty
acid oxidation as activity of HADH was decreased by 35%
(Figure 2A). We also measured the expression of genes
implicated for fat oxidation and energy metabolism. A de-
crease in expression of PGC1α (33%), MLYCD (15%) and
UCP3 (40%) was detected in myotubes under lipotoxic
condition compared to control condition (Figure 2B).
Similarly expression of muscle enriched genes like MEF2C
and MyoG were reduced by 39% and 34% respectively
under lipotoxicity (Figure 2B). Interestingly, we observed
an increase in expression of CPT1β (24%), PPARα (109%)
and PPARδ (118%) under lipotoxic condition (Figure 2B).
PGC1α is required for fat oxidation and uncoupling
genes expression and is activated by deacetylation.
Since, deacetylation process requires NAD, we next
measure NAD levels in myotubes under lipotoxicity.
Approximately 30% reduction in NAD level was ob-
served under lipotocxicity (Figure 2C). In parallel with
decrease in PGC1α and NAD levels, we observed a
24% decrease in mitochondrial DNA copy numbers in
skeletal muscle myotubes under chronic lipotoxic con-
dition (Figure 2D). In consistent with these findings,
enzymatic activity of SDH (succinate dehydrogenase)
was found to be reduced (53% of control, Figure 2E).
Taken together, lipotoxicity severely impacts mitochon-
drial number and activity, muscle fat oxidation and
redox balance.
Lipotoxicity negatively impact muscle glucose metabolism
We investigated impact of lipotoxicity on glucose metabol-
ism and found that pyruvate levels were decreased by 42%
(Figure 3A) indicating glycolysis was reduced. Moreover, a
significant increase (12%) in lactate release (29.1 μmoles/mg
AD E
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Figure 1 Lipotoxic condition augments fat uptake and storage. (A) C2C12 myotubes were treated with lipotoxic condition as described in
“Methods” followed by quantitative estimation of triglycerides (*** P < 0.001). Oil-O-red staining showing TG levels in myotubes cultured under
lipotoxic condition (C) or under control condition (B). Fatty acid uptake capacity of myotubes (D) was measured by their ability to uptake a
fluorescent fatty acid analog after chronic treatment (*** P < 0.001). After lipotoxic condition, RNA was isolated from myotubes and the mRNA
levels of FASN, GPAM and LIPIN (E) (* P < 0.05) were measured as described in the Methods.
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culture medium was observed (Figure 3B) which de-
notes increased non oxidative disposal of glucose. In
conjunction with reduced oxidation and increased
non-oxidative disposal, reduced levels of ATP were de-
tected (1.9 nano-moles/mg under lipotoxicity versus 4
nano-moles/mg under control; Figure 3C) indicating
overall attenuation in energy metabolism. Interestingly,A
C D
B
Figure 2 Lipotoxicity impairs oxidative capacity of myotubes. (A) Fatt
myotubes cultured under control or lipotoxic condition (* P < 0.05). (B) Po
measured as described in the Methods (* P < 0.05, ** P < 0.01, *** P < 0.00
(*** P < 0.001). (D) Total DNA was isolated from myotubes cultured under
(D) was estimated by assessing mtND1 (mitochondrial gene) copy number
myotubes cultured under control or lipotoxic condition (*** P < 0.001).non-oxidative disposal of glucose in form of glycogen
storage was decreased (~16%, 503 μg/mg versus 600 μg/mg
under control; Figure 3D). Expression of glucose trans-
porter Glut4 (Slc2a4) was reduced around 20% (Figure 3E)
whereas expression of basal glucose transporter Glut1/
Slc2a1 was found to be up-regulated by 2.8 fold under
lipotoxicity (Figure 3F). Thus, lipotoxicity significantly
impaired muscle glucose metabolism.E
y acid oxidation ability was measured by HADH activity in lysates of
st lipotoxic condition, mRNA levels of mentioned genes were
1). (C) Cellular NAD levels were quantified after lipotoxic treatment
control or lipotoxic condition and mitochondrial DNA copy number
normalized to HPRT (nuclear gene) (** P < 0.01). (E) SDH activity in
AD E F
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Figure 3 Impact of lipotoxic condition on glucose metabolism. (A) After lipotoxic treatment, myotubes were lysed and cellular pyruvate
levels were measured (*** P < 0.001). (B) Lactate release from myotubes was measured in culture medium collected after lipotoxic treatment
(* P < 0.05). (C) Cellular ATP levels (*** P < 0.001) and (D) glycogen storage (*** P < 0.001) were measured after lipotoxic treatment as described in
Methods. After lipotoxic treatment, RNA was isolated and mRNA levels of glucose transporter Glut4/Slc2a4 (** P < 0.01; E) and Glut1/Slc2a1
(*** P < 0.001; F) were quantified using qPCR.
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We next studied the impact of lipotoxicity on muscle insu-
lin resistance. Lipotoxic conditions caused an up-regulation
of PDK4 expression (3.3 fold; Figure 4A), a gene inversely
regulates glucose oxidation. In control myotubes, insulin
treatment significantly reduced PDK4 expression (0.54 fold)
implying insulin sensitivity and insulin mediated augmen-
tation in glucose metabolism. However, insulin treatment
failed to reduce PDK4 expression in myotubes cultured
under lipotoxic condition confirming an insulin resistant
state (Figure 4A). Acute treatment of insulin was able to
increase Akt phosphorylation in control myotubes but
not in those cultured under chronic lipotoxic conditionsPDK4 expressionA
Figure 4 Increased insulin resistance under lipotoxic condition. (A) Po
without insulin and gene expression of PDK4 was analyzed (* P < 0.05, ***
Insulin) (B) After chronic lipotoxic treatment, myotubes were serum starved
analysis of pAKT and AKT levels by Western blotting. (C) After chronic lipot
measurement by Western blotting. Beta actin was used as a loading contro(Figure 4B). Furthermore, serine phosphorylation of IRS1,
a marker of insulin resistance, was increased under lipo-
toxicity (Figure 4C). Overall, we conclude that lipotoxicity
causes insulin resistance and hence decreases muscle
glucose utilization.
Chronic lipotoxic conditions elevate oxidative stress and
ER stress
Chronic lipotoxic conditions increased oxidative stress in
myotubes as ROS levels were increased by 20% (Figure 5A).
Increase in ROS under lipotoxic conditions was accompan-
ied with increase in nitric oxide levels (Figure 5B) which
were enhanced by approximately 4 fold. We found thatB
C LipotoxControl
st chronic lipotoxic treatment, myotubes were treated for 2 h with or
P < 0.001, ns: not significant). (Con: Control; Lipotox: Lipotoxicity; Ins:
and then treated with or without insulin for 10 min followed by
oxic conditions, myotubes were harvested for p-serine-IRS1 level
l.
Figure 5 Lipotoxicity causes oxidative stress, endoplasmic reticulum stress and ceramide synthesis in myotubes. (A) Post lipotoxicity,
myotubes were loaded with DCFH-DA ROS indicator probe and amount of ROS was quantified (** P < 0.01). (B) Nitric oxide levels in culture
medium was quantified using Griess reagent (*** P < 0.001). (C) Expression of genes involved in oxidative stress, ER stress and ceramide synthesis
in myotubes cultured under lipotoxic condition were quantified by real time RT-PCR and expressed as fold levels of control (Broken line)
(* P < 0.05, ** P < 0.01, *** P < 0.001). (D) After chronic lipotoxic conditions, myotubes were harvested for CHOP level measurement by Western
blotting. Beta actin was used as a loading control. (E) For estimation of cytoplasmic calcium levels, myotubes cultured under control or lipotoxic
condition were loaded with Fluo-4 AM calcium indicator dye and the change in fluorescence was estimated as described in the Methods.
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required to counteract ROS, was down-regulated under
lipotoxicity (0.53 fold of control; Figure 5C). Expression
of SOD1, NFE2L2/NRF2 and TXNIP – proteins which
sense increased ROS levels, were up-regulated by 1.6,
1.6 and 1.3 fold respectively (Figure 5C). Similarly, ex-
pression of NOS2a/iNOS, an enzyme required for nitric
oxide synthesis, was also up-regulated under lipotoxicity
(4.3 fold of control; Figure 5C). Hence, oxidative stress
is significantly augmented under lipotoxic conditions.
Next, we examined impact of lipotoxicity on ER stress.
Both expression (Figure 5C) and protein levels (Figure 5D)
of CHOP/DDIT3 (a marker of ER stress) were significantly
increased under lipotoxic conditions. Similarly, ATF6α
(another marker of ER stress) was also found to be up-
regulated under lipotoxic conditions (2 fold of control;
Figure 5C). In parallel to CHOP and ATF6α levels,
cytoplasmic calcium levels were almost two times higher
in myotubes cultured under chronic lipotoxic conditions
compared to control myotubes (Figure 5E). Since oxida-
tive stress and ER stress in muscle are linked to increased
ceramide level, and expression of SPTLC1 (rate limiting
enzyme for de novo ceramide biosynthesis), SMPD2 and
SMPD3 (enzymes required for ceramide synthesis from
sphingomyelin) were up-regulated under lipotoxicity
(1.2, 1.3 and 2.4 fold respectively; Figure 5C). Taken to-
gether, we conclude that lipotoxic conditions increase
muscle oxidative and ER stress with potential to enhance
ceramide biosynthesis pathways.Augmentation of inflammation and inflammatory
signaling under lipotoxic conditions
We next ascertained whether chronic lipotoxicity can
cause chronic inflammation in skeletal muscle. Skeletal
muscle myotubes expressed significantly higher levels
of pro-inflammatory myokines or cytokines such as
IL6, TNFα and IL1β (Figure 6A) when cultured under
lipotoxicity. This increase in inflammation in system
led to an increase in NFκB signaling as IκB levels were
found to be decreased (Figure 6B). Similarly JNK, ERK and
STAT3 signaling were also found to be increased under
lipotoxicity as we observed increased phosphorylated
levels of these proteins (Figure 6B).
Chronic lipotoxic conditions increases apoptosis
and proteolysis
We observed that cell survival is decreased under lipotoxic
conditions (73% of control, Figure 7A) with a concomitant
increase in Caspase-3 activity (0.55 nano-moles/min/mg
versus 0.40 nano-moles/min/mg under control, Figure 7B),
an indicator of apoptosis. Releases of proteins in culture
medium (Figure 7C) as well as release of branched chain
amino acids (3.2 fold, 137 nano-moles/mg versus 43
nano-moles/mg, Figure 7D) were increased from myotubes
cultured under chronic lipotoxic conditions. Similarly,
expression of TRIM63/MURF, a marker of proteolysis,
was up-regulated under lipotoxicity (1.2 fold of control;
Figure 7E). Hence, our data confirm that muscle apoptosis
and proteolysis are increased by lipotoxic conditions.
Figure 6 Increased expression of pro-inflammatory cytokines genes and elevated stress signaling under lipotoxicity. (A) Analysis of
inflammatory cytokines mRNA levels in myotubes cultured under lipotoxic condition were quantified by real time RT-PCR and expressed as fold
levels of control (Broken line) (** P < 0.01, *** P < 0.001). (B) Total cellular lysate from myotubes cultured under control or lipotoxic conditions
was used for Western blotting of proteins as indicated.
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skeletal muscle myotubes
We next studied the possibility of using chronic lipotoxicity
system to validate potential molecular mechanism for their
impact on diabetic muscle. We targeted oxidative stressFigure 7 Lipotoxic condition causes increased apoptosis and proteoly
and caspase-3 activity assay (B, *** P < 0.001) were performed as described
proteins (C, * P < 0.05) and branched chain amino acids (BCAA) (D, * P < 0.0
of proteolysis marker Trim63 (E, *P < 0.05).using an antioxidant NAC (N-acetyl-L-cysteine) under
chronic lipotoxic conditions and studied its impact on
muscle stress and metabolism. As expected, being an
antioxidant, NAC reduced lipotoxicity induced oxidative
stress in muscle as ROS levels were decreased (Figure 8A).sis in myotubes. After chronic lipotoxicity, MTT assay (A, ** P < 0.01)
under Methods. Proteolysis was estimated by elevated release of
5) form myotubes into culture medium and up-regulated expression
ROS level
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Figure 8 Scavenging oxidative stress protects myotubes from lipotoxicity. Myotubes were cultured under control or lipotoxic conditions or
lipotoxic conditions containing N-acetyl cysteine (NAC). NAC, a ROS scavenger, reduced lipotoxicity induced ROS levels in myotubes (A, *** P < 0.001).
(B) Stress signaling as measured by JNK phosphorylation and ER stress as measured by CHOP levels were reduced by NAC. (C) This antioxidant also
reduced IMTG levels (*** P < 0.001; ** P < 0.01) and increased mitochondrial DNA copy number (D, * P < 0.05). Expression of PGC1α (E), MEF2C (F) and
CPT1β (G) genes was found to be increased by NAC (* P < 0.05, ** P < 0.01, *** P < 0.001). NAC treatment also increased cellular viability (H, *** P < 0.001;
* P < 0.05) and ATP levels (I, ** P < 0.01). (J) Lipotoxic conditions decreased and NAC treatment restored SDH activity (*** P < 0.001). (K) Insulin stimulated
glucose uptake was decreased under lipotoxic conditions and was restored by NAC treatment (* P < 0.05). ANOVA with Newman-Keuls post test was
performed for statistical analyses.
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inflammatory stress signaling and ER stress as JNK phos-
phorylation and CHOP levels were reduced (Figure 8B).
Reduction in cellular stress by NAC resulted in improved
metabolism which was observed with decreased IMTG
storage (Figure 8C), increased mitochondrial biogen-
esis (Figure 8D) along with up-regulation of PGC1α,
CPT1β and MEF2C expression (Figure 8E-G) under
lipotoxic conditions. This improvement in metabolism
also led to increased cell survival (Figure 8H) and alsoincreased ATP levels (Figure 8I) indicating improve-
ment in energy metabolism. Moreover, oxidative cap-
acity, as measured by SDH activity, was reduced under
lipotoxic conditions (59% of control) and was restored
by antioxidant treatment (Figure 8J). Insulin stimu-
lated glucose uptake was reduced under lipotoxic con-
ditions indicating development of insulin resistance in
myotubes which was restored by NAC treatment indi-
cating reduction in oxidative stress can improve insulin
sensitivity (Figure 8K).
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of dysregulation of various cellular responses under chronic
lipotoxic conditions. This system mimics cellular pathology
at various cellular responses as seen in skeletal muscle of
T2DM patients and hence provides a useful tool for study-
ing molecular mechanism or novel drug screening. Further-
more, we validated this system for its efficiency by targeting
a known molecular mechanism to overcome lipotoxic
effects on stress and metabolism.
Discussion
This study presents integrated view of lipotoxicity in-
duced gross impairment in various cellular responses of
skeletal muscle. We used fatty acid overload as condition
for inducing lipotoxicity as it is unambiguously a condition
which is present in insulin resistant and T2DM patients
(Fraze et al. 1985; Chen et al. 1987; Golay et al. 1987;
Swislocki et al. 1987; Reaven et al. 1998), and found that
all cellular and molecular parameters studied in this
paper are impaired in accordance with that seen in vivo
conditions. No appreciable cytotoxicity was observed
under the lipotoxic condition which is consistent with
the earlier reports (Sawada et al. 2012; Feng et al. 2012).
Increased fatty acid levels exert toxic impacts, generally
known as lipotoxic impacts, on a variety of cell types.
We have earlier shown that saturated fatty acid, palmi-
tate, is an important factor in deteriorating pancreatic
beta cells’ health and function (Somesh et al. 2013). In
skeletal muscle, it has been shown that palmitate treatment
can cause inhibition of insulin signaling and glucose uptake
as well as damage to mitochondria (Jové et al. 2006; Rachek
et al. 2007; Yuzefovych et al. 2010). Palmitate treatment can
also increase inflammatory cytokines gene expression and
downstream signaling, oxidative stress and ceramide syn-
thesis (Schmitz-Peiffer et al. 1999; Chavez et al. 2003; Jové
et al. 2006; Rachek et al. 2007; Yuzefovych et al. 2010).
Lipotoxicity of skeletal muscle is defined as fatty acid
overload mediated impairment in metabolism and in-
creased stress. Reduced oxidative capacity, metabolic
inflexibility and non-oxidative disposal of metabolites
are characteristics of muscle of T2DM (Simoneau and
Kelley 1997; He et al. 2001; Schrauwen and Hesselink
2004; Kim et al. 2006; Tsintzas et al. 2007). In this
study, we are able to capture these deleterious impacts
on metabolism like metabolic inflexibility or reduced
ability of muscle to switch fuel from fat to glucose as
seen in insulin resistant patients (Mensink et al. 2007).
During insulin resistance, insulin mediated glucose
oxidation comes down (Mensink et al. 2007) and hence
fat becomes primary fuel source albeit overall oxidation is
reduced. Our in vitro lipotoxic system is in agreement with
these findings that fat oxidation is predominant form of
oxidation under lipotoxic condition whereas glucose oxida-
tion is concomitantly reduced. We provide evidence thatunder lipotoxic conditions expression of key genes regulat-
ing fat oxidation such as CPT1β, PPARα and PPARδ was
increased while an increase in the expression of PDK4, a
negative regulator of glucose oxidation, was observed. Our
study also provide evidence that lipotoxic muscle are in a
state of metabolic inflexibility and link this state to insulin
resistance given that insulin treatment failed to reduce
PDK4 expression in myotubes cultured under lipotoxic
condition. This inability to switch fuel utilization from
fat to glucose is seen in insulin resistance muscle as
PDK4 expression remain elevated in response to insulin
but is reduced in insulin sensitive muscles (Kim et al.
2006; Tsintzas et al. 2007; Kulkarni et al. 2012).
Though fat oxidation is predominant form of oxidation
in insulin resistant muscle but overall oxidation is decreased
or incomplete oxidation takes place (Koves et al. 2008). Fat
oxidation and oxidative capacity are reduced in human pa-
tients (Kim et al. 2000; He et al. 2001; Oberbach et al. 2006)
with a concomitant decrease in PGC1α expression and its
downstream targets (Mootha et al. 2003; Patti et al. 2003;
Debard et al. 2004). Our in vitro data are in agreement with
these clinical findings as we report reduced fat oxidation
under lipotoxic conditions along with reduced PGC1α level
with concomitant decrease in mitochondria number and
activity. Moreover, we show that ATP levels are also de-
creased indicating reduced overall oxidation. In parallel,
we also provide evidence that NAD levels are decreased
under lipotoxic conditions and this reducing agent is re-
quired for fuel oxidation hence further validating severely
compromised oxidative capacity. Moreover, NAD is also
required for SIRT1 protein mediated deacetylation and ac-
tivation of PGC1α. Hence, it can be speculated that FFA
overload to an extent higher than that can be handled by
muscle causes lipotoxic impacts.
Packing of FFA into neutral lipid provides a possible
mechanism to refrain from its toxic impacts (Listenberger
et al. 2003). Consistent with this, we found increased IMTG
levels and up-regulation of enzyme involved in TG packing
under in vitro lipotoxicity. However, our data suggest
that this protective mechanism was clearly not enough
to completely protect myotubes from lipotoxic impacts.
In this regards, activation of any other mechanism like
increasing desaturation of fatty acid which aid TG packing
might help better protection against lipotoxicity. This might
be one of a reason that unsaturated fatty acid, oleate, does
not cause lipotoxicity (Listenberger et al. 2003; Henique
et al. 2010; Yuzefovych et al. 2010) as unsaturated fatty
acids are preferred substrate for TG formation and in-
cubation of myotubes with oleate leads to higher IMTG
levels than those achieved with saturated fatty acid at
same concentration (data not shown).
Increased fatty acid overload, uncontrolled oxidation
and synthesis of complex lipids such as ceramide lead to
increased cellular stress (Rachek et al. 2007; Yuzefovych
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signaling and produce pro-inflammatory cytokines (Jové
et al. 2006). Increase in cellular stress and inflammation
lead to mitochondrial dysfunction (Bonnard et al. 2008)
thereby further aggravating lipotoxicity. Thus, cellular
stress namely oxidative and ER stress, chronic low grade
inflammation and downstream stress signaling become
driver for the pathology of T2DM (Evans et al. 2002). Our
in vitro system of lipotoxicity also supports these findings
as we observe inflammation, oxidative and ER stress and
stress signaling.
Since previous findings showed role of cellular ROS in
inducing dysfunction of muscle and other cell types
(Oprescu et al. 2007; Nakamura et al. 2009; Yuzefovych
et al. 2010), we studied whether targeting oxidative stress
can provide protection against lipotoxicity mediated
impairments. Antioxidant mediated reduction in cellu-
lar oxidative stress led to a reduction in stress signaling
and improved metabolic function of muscle cells under
lipotoxic conditions. Antioxidant treatment improved
oxidative capacity and mitochondrial functions of myotubes
which led to efficient fat oxidation (data not shown) and
reduced IMTG storage. These findings are in consistent
with earlier reports showing that increasing muscle fatty
acid oxidation capacity can protect from insulin resistance
(Perdomo et al. 2004; Sebastián et al. 2007; Henique et al.
2010). Hence, any intervention capable of augmenting
oxidative capacity and reducing oxidative stress could
be of therapeutic importance.
Conclusions
In this study, we provide an integrated perspective of
lipotoxicity on skeletal muscle glucose and fat metabol-
ism along with stress, inflammation and stress signaling.
This integrated study can help to determine interrelation
of different cellular machinery. Moreover, this in vitro
system mimics muscle pathology as seen in T2DM patients
and hence provides a reliable system to study disease mech-
anism or therapeutic interventions. Lastly, we target one
cellular response of oxidative stress and show that this
could be a potential mechanism to alleviate cellular stress
and improve metabolic function of muscle.
Methods
Cell culture and induction of lipotoxicity
C2C12 myoblast cell line was procured from ATCC. The
cells were maintained in undifferentiated state at low
confluency in DMEM (Sigma) containing 25 mM glu-
cose, 10% fetal bovine serum (Invitrogen), penicillin and
streptomycin. For differentiation into myotubes, cells were
seeded in multi-well plates and grown till complete
confluency in growth medium and then cultured in re-
duced serum (2%) medium for next four days with
medium renewal at every alternate day. After four daysof differentiation, long multi-nucleated myotubes were
seen and these differentiated cells were used for all
experimentation.
Palmitate (Sigma) was dissolved in 50% ethanol and then
conjugated in 10% BSA to get final concentration of 5 mM.
For induction of lipotoxicity, differentiated myotubes were
cultured with BSA conjugated palmitate (750 μM) for 16 h
(Watt et al. 2012). Control myotubes were cultured with
DMEM containing equal amount of BSA and ethanol.
For some experiments as indicated, myotubes were
cultured under lipotoxicity in presence or absence of
5 mM N-acetyl-L-cysteine (NAC) (Sigma) for 16 h.
Estimation of IMTG and oil-O-red staining
After inducing lipotoxicity for 16 h, myotubes were lysed
and clear lysate was used for TG estimation using a com-
mercially available kit (DiaSys). IMTG levels were normal-
ized to cellular proteins measured using Bradford reagent
(Bio-Rad). For oil-o-red staining, myotubes were fixed with
4% formaldehyde and then incubated for 15 min with 0.7%
oil-o-red in 60% isopropanol. Cells were washed thrice and
images were captured at 10× magnification.
Measurement of fatty-acid uptake
Myotubes were washed with PBS and then incubated for
10 min with 1 μM of BODIPY dye (Molecular Probes), a
fluorescent analog of fatty acid. Cells were washed to
remove unbound dye and then excess dye was quenched
with 0.4% trypan blue for 5 min. Myotubes were lysed
and BODIPY fluorescent was estimated at 485 nm ex-
citation/528 nm emission. Bodipy fluorescent was nor-
malized to total cellular proteins and represented as %
of vehicle control.
Analysis of gene expression
Differentiated myotubes were cultured under control or
lipotoxic conditions for 16 h. Post 16 h, total RNA was
extracted using Tri reagent (Sigma) and converted into
cDNA with reverse transcriptase and random hexamer
primers (Applied Biosystems) using manufacturer’s protocol.
This cDNA (5 ng per reaction) was used for quantification
of gene expression using SYBR Green PCR Master Mix
(Eurogenetic, Belgium). Genes analyzed in this study were
FASN, GPAM, LIPIN, CPT1β, UCP3, MLYCD, MyoG,
MEF2C, PPARα, PPARδ, PGC1α, Slc2a4, Slc2a1, PDK4,
NOS2a, SOD1, GPX, NFE2L2, TXNIP, CHOP, SPTLC1,
SMPD2, SMPD3, ATF6α, Trim63, TNFα, IL1β and
IL6. β-actin or 18S rRNA was used as a housekeeping
gene control.
For PDK4 (pyruvate dehydrogenase kinase 4) expression,
myotubes were washed after chronic lipotoxic treatment and
then incubated in serum and glucose free medium for 1 h.
Subsequently, myotubes were treated with insulin (100 nM)
for 2 h and then harvested for gene expression analysis.
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(HADH) activity
To measure beta-oxidation of fatty acids, HADH enzyme
activity was measured. Cell lysates were incubated with
acetoacetyl-CoA and NADH for 1 h. Reduction in NADH
level was measured at 340 nm. HADH activity was nor-
malized to cellular protein.
Estimation of cellular NAD, Pyruvate and ATP levels
NAD, Pyruvate and ATP levels were estimated in cell
lysate using commercially available kits (EnzyChrom
NAD+/NADH Assay Kit, BioAssay Systems; EnzyChrom
Pyruvate Assay Kit, BioAssay Systems; ATP determination
kit, Invitrogen) as per manufacturer’s procotol and were
normalized to cellular protein.
Mitochondrial DNA copy number
After chronic lipotoxic treatment, total DNA (5 ng)
was used for quantitative real time PCR using a primer
pair specific to mitochondrial DNA (ND1). Mitochon-
drial DNA copy number was normalized to nuclear
DNA which was amplified using a primer pair specific
to genomic DNA (HPRT).
Estimation of succinate dehydrogenase (SDH) activity
After chronic lipotoxic treatment, myotubes were incu-
bated with KRBH containing 50 mM sodium succinate,
50 mM sucrose, 1 mM sodium azide and 0.8 mM INT
dye (p-Iodonitrotetrazolium Violet) for 30 min. For each
treatment a separate set was also kept as blank which
did not include sodium succinate. After 30 min, INT-
Formazan formed due to SDH activity was dissolved in
DMSO and measured at OD640. SDH activity was rep-
resented as % of vehicle control.
Estimation of lactate release
Lactate release was measured in cell culture super-
natant. After chronic lipotoxic treatment, cell culture
medium was collected and centrifuged to remove deb-
ris. Lactate levels were estimated using EnzyChrom
Lactate Assay Kit (BioAssay Systems) and normalized
to total cellular protein.
Measurement of glycogen levels
After chronic lipotoxic treatment, myotubes were lysed
and amount of protein was measured. Lysates were treated
with KOH solution (30%) at 95°C for 10 min followed
by precipitation of glycogen using ethanol. The glyco-
gen was converted into glucose using amylase enzyme
(1U, Megazyme) which was measured using GOD assay
(DiaSys). A control for each sample was also kept where
no enzyme was added. Glycogen levels were normalized
to total cellular proteins.Western blotting
After chronic lipotoxic treatment, myotubes were lysed
and total proteins were estimated. Equal amount of protein
(30 μg) was resolved by SDS-PAGE for immunoblotting.
Primary antibodies used are phospho-Akt, Akt, phosphor-
ERK1/2, ERK1/2, phospho-JNK, JNK, phospho-tyrosine-
STAT3, phospho-serine-STAT3, STAT3, CHOP, β-actin
(Cell Signaling Technology), phospho-serine-IRS1, IκB
(Abcam).
For estimation of Akt phosphorylation, myotubes
were washed after chronic lipotoxic treatment and then in-
cubated in serum and glucose free medium for 1 h. Subse-
quently, myotubes were treated with insulin (30 nM) for
10 min and then harvested for immunoblotting.
Measurement of cellular reactive oxygen species (ROS) level
After chronic treatments of lipotoxicity for 16 h, myotubes
were loaded with DCFH-DA dye (Invitrogen) for 1 h to
measure ROS. Cells were lysed and lysates were trans-
ferred to 96-black well plate to measure increase in
DCF fluorescence at 485 nm excitation and 528 nm
emission. Amount of ROS was normalized to total cel-
lular DNA which was measured using bis-benzamide
(Sigma) fluorescence at 360 nm excitation and 460 nm
emission. Data are represented as % of control.
Estimation of nitric oxide release
Nitric oxide release was measured in cell culture super-
natant. After lipotoxic treatment, culture medium was har-
vested followed by centrifugation to remove debris. Culture
medium was mixed with equal amount of Griess reagent
(Sigma) and incubated for 15 min prior to read absorbance
at 540 nm. Amount of nitric oxide release was quantified
by a standard curve prepared using sodium nitrite and then
normalized to total cellular proteins.
Measurement of cytoplasmic calcium level
C2C12 myoblasts were differentiated in black 96-well plate
(Corning) and were cultured under chronic lipotoxic condi-
tions or under control conditions for 16 h. Myotubes were
washed with KRBH and loaded with Fluo-4-AM, a calcium
indicator fluorescent dye (Invitrogen), at 37°C for 1 h.
Fluorescence readings were taken at 485 nm excitation and
at 520 nm emission and expressed as arbitrary fluorescence
units (AFU).
MTT assay
After chronic lipotoxic treatment, MTT dye was added
in culture medium and myotubes were further incubated
for 3 h. After incubation, reduced form of MTT (formazan)
was dissolved in DMSO and amounts were estimated
by 560 nm absorbance after correction with 640 nm
absorbance. Reduction of MTT into formazan was rep-
resented as % of control.
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After chronic lipotoxic treatment, myotubes were lysed
in lysis buffer followed by estimation of Caspase-3 activity.
Caspase-3 activity was measured by cleavage of its
substrate (Ac-DEVD-pNA; Sigma) and release of pNA
which was measured at 405 nm. Activity of caspase-3
(as nano-moles of pNA released per min) was normalized
to total cellular protein.
Estimation of muscle proteolysis and branched chain
amino acids (BCAA) release
After chronic treatment, myotubes were washed and then
incubated in KRBH for 6 h. Amount of protein secreted in
KRBH and cellular protein were measured using Bradford
assay (Bio-Rad). Amount of protein fragment release was
normalized to total cellular proteins.
BCAA were also measured in KRBH. Samples were
incubated with 100 mM glycine-KCl-KOH buffer, pH 10.5,
containing 2 mM EDTA, 4 mM NAD and 6.4U of leucine
dehydrogenase for 20 min. Levels of NADH formed, as
a surrogate for BCAA concentration, were measured at
340 nm absorbance. Amount of BCAA release was
quantified by comparing with a standard curve.
Insulin stimulated glucose uptake
After chronic lipotoxic treatment for 16 h in the presence
or absence of NAC, myotubes were starved for 30 min
followed by further incubation for 30 min in KRBH con-
taining 50 μM 2-NBDG [(2-(N-(7-Nitrobenz-2-oxa-1,3-
diazol-4-yl)Amino)-2-Deoxyglucose), a fluorescent glucose
analog; Invitrogen] in the presence or absence of 30nM
insulin. After incubation, cells were washed twice and
lysed in lysis buffer. 2-NBDG fluorescence was estimated
in the lysate at 465/540 nm excitation/emission. Amount
of 2-NBDG uptake was normalized with total cellular DNA
which was measured using bis-benzamide (Sigma). Data
are represented as % of control.
Statistical analysis
All experiments contained four biological replicates and
also repeated in separate experiments. Data are pre-
sented as mean with standard error of mean. Student’s
T-test was performed to calculate statistical significance
between control and lipotoxic conditions as represented
as * P < 0.05, ** P < 0.01 and *** P < 0.001. For antioxi-
dant treated experiments, ANOVA with Newman-Keuls
post test was performed to calculate P-values among
groups. Statistical significance is represented as * P < 0.05,
** P < 0.01 and *** P < 0.001.
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